These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. [The value of additional diagnosis in the differentiation between neuropathies and myopathies]. Delcker A; Schlote W Nervenarzt; 1990 Apr; 61(4):239-43. PubMed ID: 2162009 [No Abstract] [Full Text] [Related]
9. Idiopathic inflammatory myopathies: diagnostic criteria, classification and epidemiological features. Cox S; Limaye V; Hill C; Blumbergs P; Roberts-Thomson P Int J Rheum Dis; 2010 May; 13(2):117-24. PubMed ID: 20536595 [TBL] [Abstract][Full Text] [Related]
10. Electromyography in the evaluation of muscle diseases. Buchthal F Neurol Clin; 1985 Aug; 3(3):573-98. PubMed ID: 3900682 [TBL] [Abstract][Full Text] [Related]
12. Review: immune-mediated necrotizing myopathies--a heterogeneous group of diseases with specific myopathological features. Stenzel W; Goebel HH; Aronica E Neuropathol Appl Neurobiol; 2012 Dec; 38(7):632-46. PubMed ID: 22989019 [TBL] [Abstract][Full Text] [Related]
13. Needle electromyography and histopathologic correlation in myopathies. Sener U; Martinez-Thompson J; Laughlin RS; Dimberg EL; Rubin DI Muscle Nerve; 2019 Mar; 59(3):315-320. PubMed ID: 30414326 [TBL] [Abstract][Full Text] [Related]
14. [Inflammatory myopathies, autoimmune necrotizing myopathies and adult-onset genetic myopathies: differential diagnosis]. Dimitri D; Eymard B Rev Med Interne; 2012 Mar; 33(3):134-42. PubMed ID: 22204923 [TBL] [Abstract][Full Text] [Related]
15. Magnetic resonance imaging in the idiopathic inflammatory myopathies. Fraser DD; Frank JA; Dalakas M; Miller FW; Hicks JE; Plotz P J Rheumatol; 1991 Nov; 18(11):1693-700. PubMed ID: 1787491 [TBL] [Abstract][Full Text] [Related]
16. The multifaceted character of lymphotoxin β in inflammatory myopathies and muscular dystrophies. Creus KK; De Paepe B; Weis J; De Bleecker JL Neuromuscul Disord; 2012 Aug; 22(8):712-9. PubMed ID: 22652080 [TBL] [Abstract][Full Text] [Related]
17. Mechanomyographic determination of post-activation potentiation in myopathies. Ng AR; Arimura K; Akataki K; Mita K; Higuchi I; Osame M Clin Neurophysiol; 2006 Jan; 117(1):232-9. PubMed ID: 16325468 [TBL] [Abstract][Full Text] [Related]
18. The RAGE pathway in inflammatory myopathies and limb girdle muscular dystrophy. Haslbeck KM; Friess U; Schleicher ED; Bierhaus A; Nawroth PP; Kirchner A; Pauli E; Neundörfer B; Heuss D Acta Neuropathol; 2005 Sep; 110(3):247-54. PubMed ID: 15986224 [TBL] [Abstract][Full Text] [Related]
19. Muscle disorders: the latest investigations. Ghaoui R; Clarke N; Hollingworth P; Needham M Intern Med J; 2013 Sep; 43(9):970-8. PubMed ID: 24004391 [TBL] [Abstract][Full Text] [Related]
20. Diagnostic value of in situ muscle fiber conduction velocity measurements in myopathies. Naumann M; Reiners K Acta Neurol Scand; 1996; 93(2-3):193-7. PubMed ID: 8741142 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]